Increased incidence of urolithiasis and bacteremia during proteus mirabilis and providencia stuartii coinfection due to synergistic induction of urease activity

Journal of Infectious Diseases

Volumn 209, Issue 10, 2014, Pages 1524-1532

  Armbruster, Chelsie E ^a   Smith, Sara N ^a   Yep, Alejandra ^a   Mobley, Harry L T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

bacteremia; coinfection; Proteus mirabilis; Providencia stuartii; urease; urolithiasis.; UTI

Indexed keywords

UREASE;

ANIMAL MODEL; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL VIABILITY; CATHETER INFECTION; COCULTURE; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; IN VITRO STUDY; INCIDENCE; MIXED INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROVIDENCIA STUARTII; URINARY TRACT INFECTION; UROLITHIASIS;

BACTEREMIA; COINFECTION; PROTEUS MIRABILIS; PROVIDENCIA STUARTII; UREASE; UROLITHIASIS; UTI;

ANIMALS; BACTEREMIA; COINFECTION; ENTEROBACTERIACEAE INFECTIONS; ENZYME INDUCTION; GENE EXPRESSION REGULATION, BACTERIAL; MICE; MICE, INBRED CBA; PROTEUS INFECTIONS; PROTEUS MIRABILIS; PROVIDENCIA; UREASE; UROLITHIASIS;

EID: 84899509241     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jit663     Document Type: Article

References (41)

1. Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010; 50:625-63.
2. Dedeic-Ljubovic A, Hukic M. Catheter-related urinary tract infection in patients suffering from spinal cord injuries. Bosn J Basic Med Sci 2009; 9:2-9.
3. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon 2003; 49:71-82.
4. Siegman-Igra Y, Kulka T, Schwartz D, Konforti N. Polymicrobial and monomicrobial bacteraemic urinary tract infection. J Hosp Infect 1994; 28:49-56.
5. Rahav G, Pinco E, Silbaq F, Bercovier H. Molecular epidemiology of catheter-associated bacteriuria in nursing home patients. J Clin Microbiol 1994; 32:1031-4.
6. Kunin CM. Blockage of urinary catheters: Role of microorganisms and constituents of the urine on formation of encrustations. J Clin Epidemiol 1989; 42:835-42.
7. Breitenbucher RB. Bacterial changes in the urine samples of patients with long-term indwelling catheters. Arch InternMed 1984; 144:1585-8.
8. Mobley HLT, Warren JW. Urease-Positive Bacteriuria and Obstruction of Long-Term Urinary Catheters. J Clin Microbiol 1987; 25:2216-7.
9. Warren JW, Tenney JH, Hoopes JM, Muncie HL, Anthony WC. A Prospective Microbiologic Study of Bacteriuria in Patients with Chronic Indwelling Urethral Catheters. J Infect Dis 1982; 146:719-23.
10. Macleod SM, Stickler DJ. Species interactions in mixed-community crystalline biofilms on urinary catheters. J Med Microbiol 2007; 56: 1549-57.
11. Stickler DJ, Feneley RC. The encrustation and blockage of long-term indwelling bladder catheters: a way forward in prevention and control. Spinal Cord 2010; 48:784-90.
12. Johnson DE, Russell RG, Lockatell CV, Zulty JC, Warren JW, Mobley HL. Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection. Infect Immun 1993; 61:2748-54.
13. Jones BD, Lockatell CV, Johnson DE, Warren JW, Mobley HL. Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection. Infect Immun 1990; 58:1120-3.
14. Dattelbaum JD, Lockatell CV, Johnson DE, Mobley HLT. UreR, the Transcriptional Activator of the Proteus mirabilis Urease Gene Cluster, Is Required for Urease Activity and Virulence in Experimental Urinary Tract Infections. Infect Immun 2003; 71:1026-30.
15. Zhao H, Thompson RB, Lockatell V, Johnson DE, Mobley HLT. Use of Green Fluorescent Protein To Assess Urease Gene Expression by Uropathogenic Proteus mirabilis during Experimental Ascending Urinary Tract Infection. Infect Immun 1998; 66:330-5.
16. Burall LS, Harro JM, Li X, et al. Proteus mirabilis Genes That Contribute to Pathogenesis of Urinary Tract Infection: Identification of 25 Signature-Tagged Mutants Attenuated at Least 100-Fold. Infect Immun 2004; 72:2922-38.
17. Jones BD, Mobley HL. Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection. Infect Immun 1987; 55:2198-203.
18. Jones BD, Mobley HL. Proteus mirabilis urease: genetic organization, regulation, and expression of structural genes. J Bacteriol 1988; 170:3342-9.
19. Nicholson EB, Concaugh EA, Mobley HL. Proteus mirabilis urease: use of a ureA-lacZ fusion demonstrates that induction is highly specific for urea. Infect Immun 1991; 59:3360-5.
20. Island MD, Mobley HL. Proteus mirabilis urease: operon fusion and linker insertion analysis of ure gene organization, regulation, and function. J Bacteriol 1995; 177:5653-60.
21. Kim BN, Kim NJ, Kim MN, Kim YS, Woo JH, Ryu J. Bacteraemia due to tribe Proteeae: a review of 132 cases during a decade (1991-2000). Scand J Infect Dis 2003; 35:98-103.
22. Woods TD,Watanakunakorn C. Bacteremia due to Providencia stuartii: review of 49 episodes. South Med J 1996; 89:221-4.
23. Prentice B, Robinson BL. A review of Providencia bacteremia in a general hospital, with a comment on patterns of antimicrobial sensitivity and use. Can Med Assoc J 1979; 121:745-9.
24. Warren JW. Providencia stuartii: a common cause of antibiotic-resistant bacteriuria in patients with long-term indwelling catheters. Rev Infect Dis 1986; 8:61-7.
25. Watanakunakorn C, Perni SC. Proteus mirabilis bacteremia: a review of 176 cases during 1980-1992. Scand J Infect Dis 1994; 26:361-7.
26. Rudman D, Hontanosas A, Cohen Z, Mattson DE. Clinical correlates of bacteremia in a Veterans Administration extended care facility. J Am Geriatr Soc 1988; 36:726-32.
27. Melzer M, Welch C. Outcomes in UK patients with hospital-acquired bacteraemia and the risk of catheter-associated urinary tract infections. Postgrad Med J 2013; 89:329-34.
28. Muder RR, Brennen C, Wagener MM, Goetz AM. Bacteremia in a long-term-care facility: a five-year prospective study of 163 consecutive episodes. Clin Infect Dis 1992; 14:647-54.
29. Mobley HL, Chippendale GR, Fraiman MH, Tenney JH, Warren JW. Variable phenotypes of Providencia stuartii due to plasmid-encoded traits. J Clin Microbiol 1985; 22:851-3.
30. Johnson DE, Lockatell CV, Hall-Craigs M, Mobley HL,Warren JW. Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients. J Urol 1987; 138:632-5.
31. Hagberg L, Engberg I, Freter R, Lam J, Olling S, Svanborg Eden C. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun 1983; 40:273-83.
32. Senior BW, Bradford NC, Simpson DS. The ureases of Proteus strains in relation to virulence for the urinary tract. JMed Microbiol 1980; 13:507-12.
33. Weatherburn MW. Phenol-Hypochlorite Reaction for Determination of Ammonia. Anal Chem 1967; 39:971-&.
34. Tal S, Guller V, Levi S, et al. Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection. J Infect 2005; 50:296-305.
35. Ackermann RJ, Monroe PW. Bacteremic urinary tract infection in older people. J Am Geriatr Soc 1996; 44:927-33.
36. Al-Hasan MN, Eckel-Passow JE, Baddour LM. Bacteremia complicating gram-negative urinary tract infections: a population-based study. J Infect 2010; 60:278-85.
37. Croxall G, Weston V, Joseph S, Manning G, Cheetham P, McNally A. Increased human pathogenic potential of Escherichia coli from polymicrobial urinary tract infections in comparison to isolates from monomicrobial culture samples. J Med Microbiol 2011; 60:102-9.
38. Kline KA, Schwartz DJ, Gilbert NM, Hultgren SJ, Lewis AL. Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli. Infect Immun 2012; 80:4186-94.
39. Musher DM, Griffith DP, Yawn D, Rossen RD. Role of urease in pyelonephritis resulting from urinary tract infection with Proteus. J Infect Dis 1975; 131:177-81.
40. Himpsl SD, Lockatell CV, Hebel JR, Johnson DE, Mobley HLT. Identification of virulence determinants in uropathogenic Proteus mirabilis using signature-tagged mutagenesis. J Med Microbiol 2008; 57: 1068-78.
41. Armbruster CE, Mobley HLT. Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis. Nat Rev Micro 2012; 10:743-54.